Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption …
Over the last 12 months, insiders at Progyny, Inc. have bought $0 and sold $26.17M worth of Progyny, Inc. stock.
On average, over the past 5 years, insiders at Progyny, Inc. have bought $0 and sold $286.86M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 153,846 shares for transaction amount of $2M was made by SEIDENBERG BETH C (director) on 2019‑10‑29.
2024-11-23 | Sale | director | 200 0.0003% | $56.29 | $11,258 | -72.57% | ||
2024-07-16 | Sale | PRESIDENT | 9,030 0.0103% | $30.00 | $270,900 | -30.50% | ||
2024-06-28 | Sale | director | 1,462 0.0016% | $28.39 | $41,506 | 0.00% | ||
2024-05-01 | Sale | PRESIDENT | 4,515 0.0046% | $31.95 | $144,254 | -26.46% | ||
2024-04-01 | Sale | PRESIDENT | 6,395 0.0068% | $37.60 | $240,452 | -28.21% | ||
2024-04-01 | Sale | Executive Chairman | 1,000 0.0011% | $37.52 | $37,523 | -28.21% | ||
2024-04-01 | Sale | CHIEF FINANCIAL OFFICER | 11,165 0.0119% | $37.62 | $419,979 | -28.21% | ||
2024-03-27 | Sale | Executive Chairman | 71,272 0.0735% | $37.80 | $2.69M | -30.48% | ||
2024-03-26 | Sale | Executive Chairman | 305 0.0003% | $37.50 | $11,439 | -28.40% | ||
2024-03-25 | Sale | Executive Chairman | 2,597 0.0027% | $37.65 | $97,778 | -28.19% | ||
2024-03-21 | Sale | Executive Chairman | 5,826 0.0061% | $37.74 | $219,877 | -28.11% | ||
2024-03-01 | Sale | PRESIDENT | 11,009 0.0117% | $36.63 | $403,260 | -25.07% | ||
2024-03-01 | Sale | CHIEF FINANCIAL OFFICER | 12,610 0.0134% | $36.64 | $461,977 | -25.07% | ||
2024-02-06 | Sale | PRESIDENT | 2,260 0.0024% | $40.00 | $90,400 | -31.20% | ||
2024-02-05 | Sale | Executive Chairman | 20,000 0.0209% | $38.50 | $769,928 | -29.31% | ||
2024-02-02 | Sale | Executive Chairman | 30,000 0.0316% | $38.92 | $1.17M | -29.75% | ||
2024-02-01 | Sale | PRESIDENT | 6,395 0.0066% | $37.89 | $242,307 | -29.06% | ||
2024-02-01 | Sale | Executive Chairman | 30,000 0.0311% | $38.29 | $1.15M | -29.06% | ||
2024-02-01 | Sale | CHIEF FINANCIAL OFFICER | 12,651 0.013% | $37.84 | $478,767 | -29.06% | ||
2024-01-08 | Sale | Executive Chairman | 66,002 0.0686% | $37.88 | $2.5M | -26.60% |
SEIDENBERG BETH C | director | 8805015 10.3402% | $15.44 | 1 | 4 | +60.32% |
BlackRock | $425.22M | 11.71 | 11.15M | -7.97% | -$36.84M | 0.01 | |
The Vanguard Group | $317.1M | 8.73 | 8.31M | +0.5% | +$1.59M | 0.01 | |
Tpg Gp A Llc | $251.7M | 6.93 | 6.6M | 0% | +$0 | 4.87 | |
JPMorgan Chase | $134.76M | 3.71 | 3.53M | +10.43% | +$12.72M | 0.01 | |
ClearBridge Investments | $133.41M | 3.67 | 3.5M | +0.13% | +$178,313.08 | 0.11 |